02/07/2024 Healthcare
CLAVSAT-375 tablets combine Amoxicillin and Potassium Clavulanate, offering a potent antibiotic therapy. Amoxicillin, a penicillin derivative, inhibits bacterial cell wall synthesis. Potassium Clavulanate enhances Amoxicillin's efficacy by inhibiting bacterial beta-lactamase enzymes that can degrade Amoxicillin. This combination treats a wide range of bacterial infections, including respiratory tract infections and urinary tract infections, ensuring effective bacterial eradication and reducing the risk of antibiotic resistance.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations
CLAVSAT-375 tablets combine Amoxicillin and Potassium Clavulanate, offering a potent antibiotic therapy. Amoxicillin, a penicillin derivative, inhibit...
"CLAVSAT-625 tablets combine Amoxicillin and Potassium Clavulanate to treat bacterial infections effectively. Amoxicillin, a penicillin antibiotic, in...
Clavsat 1.2, an Amoxicillin Potassium Clavulanate Injection, combines the antibiotic properties of amoxicillin with the beta-lactamase inhibitor clavu...
**Stapolin-CV** combines Cefpodoxime Proxetil and Potassium Clavulanate in tablet form, enhancing antibacterial efficacy. Cefpodoxime, a third-generat...
More Details